0001363585-12-000010.txt : 20120627 0001363585-12-000010.hdr.sgml : 20120627 20120627160937 ACCESSION NUMBER: 0001363585-12-000010 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120625 FILED AS OF DATE: 20120627 DATE AS OF CHANGE: 20120627 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FELLOWS STEPHEN CENTRAL INDEX KEY: 0001363585 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-25169 FILM NUMBER: 12929636 MAIL ADDRESS: STREET 1: C/O SONA MOBILE HOLDINGS CORP STREET 2: 825 THIRD AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J 2G2 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CA STATE: A1 ZIP: M5J 2G2 4 1 primary_doc.xml PRIMARY DOCUMENT X0305 4 2012-06-25 0 0001059784 GENEREX BIOTECHNOLOGY CORP GNBT 0001363585 FELLOWS STEPHEN 33 HARBOUR SQUARE SUITE 202 TORONTO A6 M5J 2G2 ONTARIO, CANADA 0 1 0 0 Acting Chief Financial Officer Common Stock 2012-06-25 4 S 0 546448 0.0922 D 0 D The shares sold were acquired by the reporting person on June 21, 2012 upon exercise of options to purchase 546,448 shares of the issuer's common stock, which were granted by the Board of Directors on June 6, 2012 in lieu of cash payment of deferred compensation. The option grant was effective upon the reporting person's execution of a Settlement and Release Agreement with the issuer on June 20, 2012 and was made pursuant to the terms of the issuer's 2006 stock plan. Stephen Fellows 2012-06-27